New algorithm identifies patients harboring tumor-causing defect found in multiple cancers
Medications known as PARP inhibitors have emerged as a promising therapy for several forms of cancer fueled by a defect
Read more
Medications known as PARP inhibitors have emerged as a promising therapy for several forms of cancer fueled by a defect
Read moreThe ability to turn while walking is impaired among patients with Parkinson’s disease. This difficulty is also associated with freezing
Read moreResearchers at Humacyte, a biotechnology and regenerative medicine company, have published an article in Science Translational Medicine demonstrating that the
Read moreFrom shaking while drinking a cup of tea to needing a nap in the afternoon: Brain cancer patients reveal the
Read morePatients at high risk for heart attacks, strokes and blood clots who were treated with a novel blood thinner (apixaban)
Read moreEven though most medical practitioners may opt not to perform procedures on higher-risk patients, new research finds that it may
Read moreSpending on post-acute care continues to rise in the United States. Today, nearly 90 percent of Medicare patients discharged to
Read moreClinicians should consider using PCSK9 inhibitors to lower cholesterol in patients with statin-associated autoimmune myopathy. Findings from a case report
Read moreTUESDAY, Feb. 12, 2019 — Stroke patients who receive intensive blood pressure lowering are less likely to suffer brain bleeds
Read moreAn end to insulin shots? Diabetes patients could take a pill containing tiny NEEDLES that inject insulin in the stomach
Read more